Hansa Biopharma closes EUR115m Licensing Deal with SERB Pharmaceuticals for Idefirix

SciBase submits FDA filing to expand Nevisense use to non‑melanoma skin cancers

Galderma receives FDA Complete Response Letter for RelabotulinumtoxinA US filing

AbbVie receives positive CHMP opinion for upadacitinib in severe alopecia areata

AbbVie receives positive CHMP opinion for upadacitinib in non‑segmental vitiligo

genedrive partners with Thermo Fisher Scientific to develop high-throughput CYP2C19 test

Sobi receives US FDA's complete response letter for NASP (nanoencapsulated sirolimus plus pegadricase)

Anivive Lifesciences' Laverdia receives FDA approval to treat canine lymphoma

Lupin's Enzalutamide Tablets receive for tentative US FDA approval

Vifor Fresenius and CSL announce European regulator recommends revoking TAVNEOS (avacopan) marketing authorisation

bioMérieux files FDA application for rapid vaginitis diagnostic panel

FDA approves Merck's Keytruda combinations for first-line treatment of PD-L1-positive advanced triple-negative breast cancer

Ionis licenses ex-US rights to zilganersen for Alexander disease to Recordati

Dicot Pharma receives FDA clearance to start Phase 2b study of LIB-01 in US

CeleCor Therapeutics submits final section of zalunfiban (Disaggpro) New Drug Application to US FDA